New asthma drug trial aims to reduce dangerous attacks
NCT ID NCT06323213
Summary
This study is testing whether an experimental drug called 610 can help control severe asthma in Chinese adults. Researchers will compare 610 against a placebo in 480 participants over 52 weeks of treatment. The main goal is to see if 610 reduces the number of serious asthma flare-ups that require medical attention.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai General Hospital
RECRUITINGShanghai, Shanghai Municipality, China
Conditions
Explore the condition pages connected to this study.